anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

Image

Component collection for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Matching slides 119,566
Current window 66,931-66,960
Pages 3,986
Rows per page 30
Component: Imageclear collectionreset all
18 30 60

Component

66,931-66,960 of 119,566

filter-aware
18
The slide uses a narrative of past professional failure and alleged fraud to undermine the credibility of the current CFO.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The Monster1 hit
25
The slide uses highly critical, adversarial language ('toxic drug', 'face-planted', 'questionable French lab') to frame the company negatively.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The MonsterLoop · Aha Moment1 hit
29
The slide uses a scientific diagram to explain the mechanism while simultaneously casting doubt on the underlying theory.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The MonsterLoop · Aha Moment1 hit
32
The slide uses a narrative of past professional failure to cast doubt on current leadership.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The Struggle1 hit
34
The slide uses a WSJ article as a source to expose the CEO's attempt to distance himself from a controversial business practice.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The Struggle1 hit
58
Includes a visual comparison of pharmacophore models and a specific reference to ABT-239.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The VictoryLoop · The Reveal1 hit
65
The slide uses a 'before-after' or 'evidence-based' contradiction structure to undermine the value of the licensed asset.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The Victory1 hit
66
The slide uses a 'quote-and-commentary' structure to expose potential corporate malfeasance or negligence.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The Victory1 hit
67
The slide uses historical publication data to cast doubt on the quality of the drug pitolisant by highlighting that the inventor prioritized other compounds.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The Victory1 hit
68
The slide uses a 'fraud-exposure' narrative, highlighting a specific omission in a scientific paper to imply corporate malfeasance.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The Victory1 hit
71
The slide uses a combination of chemical structure diagrams, a tabular summary of clinical trial failures, and a pie chart showing the distribution of indications for failed trials.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
124
The slide uses a specific FDA review document (NDA 211150) to challenge official plasma level claims.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
181
The slide presents a clinical case narrative alongside screenshots of FDA FAERS database records.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
185
The slide presents a narrative summary of a medical case report, pointing out suspicious physician/company behavior regarding the reporting of heart palpitations.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
186
The slide presents a clinical case study from the FDA FAERS database, highlighting a potential drug-drug interaction or confounding factor.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
187
This is a clinical case report document from the FDA Adverse Event Reporting System (FAERS).Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
188
This is a raw FDA FAERS FOIA case report document.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
189
The slide presents a clinical case study analysis of a specific adverse event report (FAERS).Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
190
This slide presents raw clinical case data from the FDA FAERS database to support a hypothesis about drug interactions.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
192
The slide highlights a specific safety concern regarding pitolisant (Wakix) and its interaction with CYP2D6 inhibitors.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
198
This appears to be a medical case report document from the FDA FAERS database.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
201
The slide presents a patient-reported adverse event (FAERS) to challenge the safety profile of a pharmaceutical product.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
214
The slide uses excerpts from French regulatory documents to prove the existence and negative results of the unpublished HARMONY 4 trial.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
217
The slide uses a screenshot of the ESS website to undermine the credibility of the clinical trial endpoint.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
218
The slide uses visual evidence of four different versions of the ESS form to support the claim that the scale lacks a single, consistent format.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
224
The slide uses a 'red flag' argument to suggest data manipulation or p-hacking via sample size adjustment.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
230
The slide uses a redacted document image to illustrate the lack of transparency in the FDA's review process compared to the EMA's.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
244
The slide uses a comparative analysis of clinical trial data to challenge the validity of the HARMONY 3 results.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
295
The slide uses a screenshot of the Wakix website to highlight the specific claim being challenged.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
312
The slide uses a combination of summary text, a screenshot of the original study abstract, and a pull-quote from an expert review to discredit the study's findings.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit